Patent · US Expired

Esters of 3'-deaminodoxorubicin and liposomal compositions thereof

US5132290A · kind A · utility

7Cited by
29References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 30, 1989
Grant dateJul 21, 1992
Priority date
Expiry dateMay 30, 2009

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H15/207
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Three'-deaminodoxorubicin esters have been found to have excellent encapsulization efficiency in liposomes and to display high antineoplastic activity. The liposomal formulations have also been found to be quite stable.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.